Will This Diet Device Be a Blockbuster?


Shutterstock photo

The latest Bloomberg Businessweek describes an implantable device called Abiliti that could be a boon for people who are overweight. It sends electrical pulses to the stomach and makes people feel full.

The company making this, IntraPace, is privately held, but investors include Boston Scientific ( BSX ) and Johnson & Johnson ( JNJ ).

BSX data by YCharts

It would be too early to call this so-called "gastric pacemaker" the cure for obesity. While approved in Europe, Alibiti doesn't yet have any long-term studies available that show how well it works. But if you're looking for investment opportunities presented by our unfortunate obesity epidemic, keep this one in your back pocket and check out this YCharts story for other ideas.

From the editors of YCharts. YCharts Pro Investor Service includes professional stock charts , stock ratings and portfolio strategies .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: investing Stocks
Referenced Stocks: BSX , JNJ

More from YCHARTS




Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com